MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
35.27
+0.27
+0.77%
After Hours: 35.27 0 0.00% 17:41 12/04 EST
OPEN
35.19
PREV CLOSE
35.00
HIGH
35.82
LOW
34.52
VOLUME
45.84K
TURNOVER
--
52 WEEK HIGH
39.71
52 WEEK LOW
7.75
MARKET CAP
557.87M
P/E (TTM)
-7.3278
1D
5D
1M
3M
1Y
5Y
1D
Companies Like Assembly Biosciences (NASDAQ:ASMB) Can Afford To Invest In Growth
Simply Wall St · 2d ago
Weekly Report: what happened at ASMB last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at ASMB last week (1117-1121)?
Weekly Report · 11/24 09:23
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Assembly Biosciences (ASMB)
TipRanks · 11/21 14:20
Assembly Biosciences Is Maintained at Outperform by Mizuho
Dow Jones · 11/20 16:41
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $40
Benzinga · 11/20 16:31
Assembly Biosciences price target raised to $40 from $29 at Mizuho
TipRanks · 11/20 12:10
ASSEMBLY BIOSCIENCES INC <ASMB.O>: MIZUHO RAISES TARGET PRICE TO $40 FROM $29
Reuters · 11/20 11:49
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.